Q1 Website Surge: Social media chatter centers on Lemonade's website drawing 9.46 million visits in Q1 2026, up 43% from last year—the sharpest quarterly rise on record. Participants view this as a bullish harbinger for impending earnings, signaling robust customer momentum. The data has sparked optimism about the company's scaling trajectory.
Price Action Scrutiny: Traders spotlight a gap fill creating an attractive risk-reward setup, eyeing $65 if momentum persists, despite intraday new lows. Young demographics' affinity for pet insurance emerges as a key tailwind bolstering long-term prospects. Improving loss ratios and reinsurance shifts draw technical bulls back to trendline holds.
Path to Profitability: Enthusiasts underscore explosive growth since IPO, with in-force premiums surging 460% and EBITDA profitability in sight. AI efficiencies and charitable model win accolades, though catastrophe exposure tempers some views. Watchlist inclusions highlight enduring appeal amid volatility.
Note: This discussion summary was generated from an AI condensation of post data.
Lemonade Insider Trading Activity
Lemonade insiders have traded $LMND stock on the open market 26 times in the past 6 months. Of those trades, 0 have been purchases and 26 have been sales.
Here’s a breakdown of recent trading of $LMND stock by insiders over the last 6 months:
- DANIEL A. SCHREIBER (Chief Executive Officer) has made 0 purchases and 2 sales selling 135,733 shares for an estimated $12,898,508.
- ADINA ECKSTEIN (Chief Operating Officer) has made 0 purchases and 9 sales selling 132,620 shares for an estimated $10,233,820.
- JOHN SHELDON PETERS (Chief Insurance Officer) has made 0 purchases and 9 sales selling 55,970 shares for an estimated $4,217,689.
- TIMOTHY E BIXBY (Chief Financial Officer) has made 0 purchases and 3 sales selling 34,997 shares for an estimated $2,580,488.
- DEBRA SCHWARTZ sold 4,200 shares for an estimated $351,078
- MAYA PROSOR (Chief Business Officer) has made 0 purchases and 2 sales selling 421 shares for an estimated $25,579.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Lemonade Revenue
Lemonade had revenues of $228.1M in Q4 2025. This is an increase of 53.29% from the same period in the prior year.
You can track LMND financials on Quiver Quantitative's LMND stock page.
Lemonade Hedge Fund Activity
We have seen 189 institutional investors add shares of Lemonade stock to their portfolio, and 131 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SOFTBANK GROUP CORP. removed 2,638,428 shares (-74.0%) from their portfolio in Q4 2025, for an estimated $187,803,305
- M&T BANK CORP added 1,069,228 shares (+inf%) to their portfolio in Q4 2025, for an estimated $76,107,649
- JPMORGAN CHASE & CO added 977,260 shares (+27.9%) to their portfolio in Q4 2025, for an estimated $69,561,366
- PRICE T ROWE ASSOCIATES INC /MD/ added 965,321 shares (+186.0%) to their portfolio in Q4 2025, for an estimated $68,711,548
- D. E. SHAW & CO., INC. removed 656,369 shares (-36.1%) from their portfolio in Q4 2025, for an estimated $46,720,345
- BANK OF AMERICA CORP /DE/ removed 594,145 shares (-71.5%) from their portfolio in Q4 2025, for an estimated $42,291,241
- BIT CAPITAL GMBH added 572,248 shares (+45.6%) to their portfolio in Q4 2025, for an estimated $40,732,612
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Lemonade Analyst Ratings
Wall Street analysts have issued reports on $LMND in the last several months. We have seen 2 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- Cantor Fitzgerald issued a "Overweight" rating on 01/14/2026
- Keefe, Bruyette & Woods issued a "Underperform" rating on 11/25/2025
- Citizens issued a "Market Outperform" rating on 11/24/2025
- Morgan Stanley issued a "Underweight" rating on 11/17/2025
To track analyst ratings and price targets for Lemonade, check out Quiver Quantitative's $LMND forecast page.
Lemonade Price Targets
Multiple analysts have issued price targets for $LMND recently. We have seen 6 analysts offer price targets for $LMND in the last 6 months, with a median target of $82.5.
Here are some recent targets:
- Bob Huang from Morgan Stanley set a target price of $85.0 on 03/17/2026
- Tommy McJoynt from Keefe, Bruyette & Woods set a target price of $44.0 on 02/24/2026
- Ryan Tunis from Cantor Fitzgerald set a target price of $92.0 on 01/14/2026
- Arvind Ramnani from Truist Securities set a target price of $98.0 on 01/06/2026
- Matthew Carletti from Citizens set a target price of $80.0 on 11/24/2025
- John Barnidge from Piper Sandler set a target price of $55.0 on 10/10/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
